Dimensional Fund Advisors’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $942K | Buy |
+46,851
| New | +$942K | ﹤0.01% | 2901 |
|
|
2023
Q3 | – | Sell |
-23,762
| Closed | -$485K | – | 3482 |
|
|
2023
Q2 | $485K | Buy |
23,762
+13,847
| +140% | +$283K | ﹤0.01% | 3071 |
|
|
2023
Q1 | $217K | Buy |
9,915
+942
| +10% | +$20.6K | ﹤0.01% | 3187 |
|
|
2022
Q4 | $147 | Buy |
8,973
+1,907
| +27% | +$31 | ﹤0.01% | 3279 |
|
|
2022
Q3 | $64K | Buy |
+7,066
| New | +$64K | ﹤0.01% | 3377 |
|